Kewaunee Scientific Corp insider trading
Every open-market purchase and sale by Kewaunee Scientific Corp's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Kewaunee Scientific Corp’s insiders pay?
From July 6, 2010 to January 8, 2026, 17 insiders reported 21 open-market purchases and 55 sales not made under a pre-set plan in Kewaunee Scientific Corp. Twelve months after each purchase was reported, the shares were +4.8% against the S&P 500 on average (median −3.6%), over 21 purchases with a full year of prices; 48% beat the index. After sales, the shares moved +2.6% against the index over 12 months (a negative figure means selling was the right call). Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on July 7, 2010 into $98,834 by November 2, 2026, +15.1% a year. It held shares 72% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $74,738 (+13.1% a year), and held throughout $94,920 (+14.8%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Hull Thomas David III | President, CEO | 0 | — | — | 18 | +3.5% (13) | January 8, 2026 |
| Gardner Donald T. III | Chief Financial Officer | 0 | — | — | 10 | +1.9% (9) | January 7, 2026 |
| Shaw Donald F. | Director | 7 | +3.8% (7) | 43% | 0 | — | December 21, 2020 |
| Russell John | Director | 6 | +17.0% (6) | 50% | 0 | — | December 15, 2023 |
| Parker David Michael | Senior VP - Finance and CFO | 0 | — | — | 5 | −19.3% (5) | July 22, 2015 |
| Phillips Elizabeth D | VP - Human Resources | 0 | — | — | 5 | +14.7% (5) | October 2, 2025 |
| Dahlgren Dana L | VP - Sales and Marketing | 1 | +4.6% (1) | 100% | 3 | −12.7% (3) | July 25, 2014 |
| Gehl Keith M | Director | 4 | −10.2% (4) | 25% | 0 | — | April 7, 2025 |
| Batdorff Douglas J. | VP of Manufacturing Operations | 0 | — | — | 3 | +14.8% (3) | January 2, 2025 |
| Mccrory Patrick Lloyd | Director | 0 | — | — | 3 | −4.3% (3) | December 18, 2012 |
| Noble Ryan S. | VP-Sales & Marketing-Americas | 0 | — | — | 3 | +4.9% (3) | January 6, 2025 |
| Ranade Mandar | VP-Information Technology | 0 | — | — | 2 | +21.4% (2) | March 28, 2024 |
| Rindoks Kurt P | VP - Engineering | 0 | — | — | 2 | −6.4% (2) | September 4, 2014 |
| Mccanless Ross W | Director | 1 | −29.0% (1) | 0% | 0 | — | July 6, 2010 |
| Rausch David M. | President, CEO | 1 | +21.7% (1) | 100% | 0 | — | July 10, 2013 |
| Rhind David S. | Director | 0 | — | — | 1 | +47.5% (1) | September 11, 2015 |
| Smith Keith D | VP - Manufacturing | 1 | +14.9% (1) | 100% | 0 | — | September 23, 2011 |
When several insiders traded Kewaunee Scientific Corp
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Kewaunee Scientific Corp in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 2 buying crowds with six months of prices, it averaged −12.8% against the index. After 4 selling crowds, −1.3%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| October 31, 2025 | 3 selling | −4.5% | −17.9% | not yet |
| December 31, 2024 | 3 selling | −31.5% | −12.1% | −56.6% |
| December 29, 2023 | 4 selling | +10.2% | +40.3% | +87.9% |
| December 31, 2020 | 2 buying | −11.4% | −0.1% | −27.1% |
| September 30, 2013 | 3 selling | −18.1% | −15.4% | −12.8% |
| September 30, 2011 | 2 buying | −17.8% | −25.5% | +4.6% |